Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Roche
Company Monitoring Page for Roche
latest headlines for company on cafepharma
Roche wins FDA OK for targeted drug in early lung cancer
BioPharma Dive
Fri, 04/19/24 - 11:40 am
Tags:
Roche
,
Alecensa
,
ALK inhibitors
,
FDA
,
non-small cell lung cancer
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
Xtalks
Thu, 04/18/24 - 10:28 pm
Tags:
Roche
,
FDA
,
Medtech
,
Eli Lilly
,
Elecsys pTau217
,
Alzheimer's disease
,
diagnostics
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Fierce Pharma
Wed, 04/17/24 - 11:33 am
Tags:
Roche
,
Ocrevus
,
MS
,
multiple sclerosis
,
AAN
Pfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
Fierce Biotech
Wed, 04/17/24 - 11:20 am
Tags:
Pfizer
,
R&D
,
Roche
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Clinical Trials Arena
Mon, 04/15/24 - 11:07 am
Tags:
Roche
,
clinical trials
,
Columvi
,
DLBCL
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sun, 04/14/24 - 01:26 pm
Tags:
Roche
,
Genentech
,
cell therapy
,
cancer
,
Adaptimmune
FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test
Pharmaphorum
Thu, 04/11/24 - 10:52 am
Tags:
diagnostics
,
Roche
,
Eli Lilly
,
Alzheimer's disease
,
FDA
,
breakthrough designation
5 Successful Phase III Oncology Trials in Q1
BioSpace
Tue, 04/9/24 - 11:50 am
Tags:
oncology
,
clinical trials
,
Bristol Myers Squibb
,
Opdivo
,
Yervoy
,
liver cancer
,
Pfizer
,
DLBCL
,
Adcetris
,
Asieris
,
HSIL
,
APL-1702
,
cervical cancer
,
Novocure
,
non-small cell lung cancer
,
Roche
,
Genentech
,
Tecentriq
,
esophageal squamous cell carcinoma
Roche autoimmune disease drug disappoints in closely watched trial
BioPharma Dive
Thu, 03/21/24 - 06:36 pm
Tags:
Roche
,
Chugai
,
clinical trials
,
myasthenia gravis
,
Enspryng
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Tags:
Pfizer
,
Braftovi
,
Roche
,
Zelboraf
,
melanoma
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Tags:
Bristol Myers Squibb
,
immuno-oncology
,
Opdivo
,
Yervoy
,
liver cancer
,
AstraZeneca
,
Roche
Lonza adds biologics capacity with $1.2bn Roche deal
Pharmaphorum
Wed, 03/20/24 - 11:17 am
Tags:
Roche
,
Lonza
,
drug manufacturing
,
Switzerland
,
CDMOs
Roche Plots Neuro Comeback with Promising Mid-Stage Alzheimer’s Data
BioSpace
Tue, 03/12/24 - 11:14 am
Tags:
Roche
,
Alzheimer's disease
,
monoclonal antibodies
Roche to take on Abbott, Dexcom with its first CGM
Medtech Dive
Fri, 03/8/24 - 11:13 am
Tags:
Medtech
,
Roche
,
CGMs
,
diabetes
,
Abbott Labs
,
DexCom
,
Accu-Chek Smartguide
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Forbes
Wed, 03/6/24 - 11:25 am
Tags:
Roche
,
Novartis
,
Xolair
,
insurers
,
food allergies
Roche, Alnylam say blood pressure drug succeeds in mid-stage trial
Reuters
Tue, 03/5/24 - 11:07 am
Tags:
Roche
,
Alnylam Pharmaceuticals
,
clinical trials
,
hypertension
,
zilebesiran
Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Tags:
Roche
,
generics
,
Esbriet
,
IPF
Roche evaluates options for its lung disease drug
Reuters
Mon, 02/26/24 - 05:12 pm
Tags:
Roche
,
Esbriet
,
lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
Tags:
oncology
,
clinical trials
,
Daiichi Sankyo
,
AstraZeneca
,
Enhertu
,
metastatic breast cancer
,
Gilead Sciences
,
Trodelvy
,
bladder cancer
,
GSK
,
Zejula
,
Jemperli
,
ovarian cancer
,
Roche
,
tiragolumab
,
Tecentriq
,
non-small cell lung cancer
,
Cue Biopharma
,
CUE-101
,
head and neck cancer
,
Elicio Therapeutics
,
ELI-002
,
solid tumors
Roche's Xolair reduces reactions to severe food allergies in study
Reuters
Sun, 02/25/24 - 05:36 pm
Tags:
Roche
,
Novartis
,
Xolair
,
clinical trials
,
food allergies
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.